From February 21, 2024 to March 31, 2024, the company has repurchased 497,440 shares, representing 0.09% for CNY 28.68 million. With this, the company has completed the repurchase of 497,440 shares, representing 0.09% for CNY 28.68 million under the buyback announced on February 21, 2024.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.66 CNY | +2.83% |
|
+3.36% | -21.66% |
Jul. 02 | Autobio Diagnostics Gets Registration Certificates for 14 Devices | MT |
May. 21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.66% | 3.47B | |
-6.61% | 12.07B | |
+91.42% | 8.2B | |
-18.38% | 6.59B | |
+9.13% | 5.89B | |
+5.36% | 2.52B | |
+40.96% | 2.48B | |
+17.72% | 2.3B | |
-18.43% | 1.58B | |
-9.77% | 1.36B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.